IMRIMRICOR MEDICAL SYSTEMS INC.
Announcement history available from 1 August 2025
Fromto
| Date / Time | Title | Type | MS | Report Codes | |
|---|---|---|---|---|---|
| 10 Aug 2026, 18:50 | Imricor U.S. Commercial Momentum Accelerates | Company Update | MS | 11001 | |
| 10 Aug 2026, 18:39 | 1H 2026 Investor Presentation | Presentations | — | 03026 | |
| 10 Aug 2026, 18:39 | 2026 Q2 Form 10-Q | Periodic Reports | MS | 03014 | |
| 10 Aug 2026, 18:38 | Q2 CY2026 Quarterly Activities Report & Form 10-Q Submission | Periodic Reports | MS | 03014 | |
| 7 Aug 2026, 18:31 | Philips Declares Compatibility with Imricor | Company Update | MS | 11001 | |
| 4 Aug 2026, 18:58 | Q2 FY26 Results Webinar Notification | Presentations | — | 03027, 14014 | |
| 27 July 2026, 18:34 | Imricor Launches U.S. Commercial Operations | Company Update | MS | 11001 | |
| 20 July 2026, 19:25 | Imricor Submits All Remaining 510(k) Devices to FDA | Company Update | MS | 11001 | |
| 15 July 2026, 03:19 | Notification regarding unquoted securities - IMR | Other | — | 06021 | |
| 13 July 2026, 21:35 | Cleansing Notice | Securities Administration | — | 06018 | |
| 13 July 2026, 21:30 | Application for quotation of securities - IMR | Other | — | 06020 | |
| 2 July 2026, 18:33 | Imricor Receives FDA Pediatric Clearances for iMR Device | Company Update | MS | 11001 | |
| 26 June 2026, 18:58 | Form S-8 Registration Statement | Securities Administration | — | 06009 | |
| 11 June 2026, 18:55 | Submission of the Third PMA Module to the US FDA for Review | Company Update | MS | 11001 | |
| 27 May 2026, 19:13 | Granting of ASX Waiver - US Financial Reporting Requirements | Securities Administration | — | 12016 | |
| 21 May 2026, 19:36 | Notification of cessation of securities - IMR | Other | — | 06027 | |
| 21 May 2026, 19:33 | Update - Notification regarding unquoted securities - IMR | Other | — | 06021 | |
| 20 May 2026, 19:57 | Appendix 3Y - AD | Director Interests | — | 02009 | |
| 20 May 2026, 19:56 | Appendix 3Y - PM | Director Interests | — | 02009 | |
| 20 May 2026, 19:56 | Appendix 3Y - AM | Director Interests | — | 02009 | |
| 20 May 2026, 19:55 | Appendix 3Y - MT | Director Interests | — | 02009 | |
| 20 May 2026, 19:53 | Appendix 3Y - SW | Director Interests | — | 02009 | |
| 20 May 2026, 19:34 | Notification regarding unquoted securities - IMR | Other | — | 06021 | |
| 20 May 2026, 04:00 | Becoming a substantial holder | Substantial Holders | — | 02001 | |
| 18 May 2026, 19:44 | Application for quotation of securities - IMR | Other | — | 06020 | |
| 18 May 2026, 19:26 | Amendment to Form 10 | Company Update | — | 11001, 12008 | |
| 8 May 2026, 22:09 | Results of Meeting | Meetings & Governance | — | 08003 | |
| 8 May 2026, 20:37 | Cleansing Notice | Securities Administration | — | 06018 | |
| 8 May 2026, 20:33 | Application for quotation of securities - IMR | Other | — | 06020 | |
| 8 May 2026, 19:27 | Release from Voluntary Escrow | Securities Administration | — | 06009 | |
| 8 May 2026, 18:23 | AGM Presentation Slides | Presentations | — | 03026 | |
| 8 May 2026, 18:22 | Chair's Address for AGM | Letters & Addresses | — | 15002 | |
| 4 May 2026, 19:49 | Equity Raising Presentation | Presentations | — | 03026 | |
| 4 May 2026, 19:12 | Proposed issue of securities - IMR | Securities Administration | — | 06013 | |
| 4 May 2026, 19:12 | Imricor Completes Successful A$60 Million Capital Raise | Capital Raising | MS | 06003, 09014 | |
| 30 Apr 2026, 19:59 | Trading Halt | Trading Halt / Suspension | MS | 09007 | |
| 30 Apr 2026, 19:51 | Pause in Trading | Trading Halt / Suspension | MS | 09005 | |
| 28 Apr 2026, 18:25 | Imricor Q1 CY26 Quarterly Activities Report and Appendix 4C | Quarterly Reports | MS | 19001, 19006 | |
| 27 Apr 2026, 18:43 | Amendment to Form 10 | Company Update | MS | 11001, 12008 | |
| 17 Apr 2026, 02:15 | Notification regarding unquoted securities - IMR | Other | — | 06021 | |
| 8 Apr 2026, 18:44 | Imricor Submits NorthStar for U.S. Pediatric Expansion | Company Update | MS | 11001 | |
| 27 Mar 2026, 20:26 | Notice of Annual Stockholders Meeting and CDI Voting Form | Presentations | — | 08001, 08004, 14014, 16002 | |
| 27 Mar 2026, 20:24 | Annual Report to shareholders | Financial Results | — | 03001, 03002, 03011, 03012, 03020 | |
| 27 Mar 2026, 20:20 | Appendix 4G and Corporate Governance Statement | Company Administration | — | 03024, 03025 | |
| 19 Mar 2026, 20:02 | Form 10 Registration with the U.S. SEC | Company Update | MS | 11001, 12008 | |
| 25 Feb 2026, 18:45 | FY25 Results Investor Presentation | Financial Results | MS | 03003, 03026 | |
| 25 Feb 2026, 18:45 | Imricor Releases FY25 Results | Financial Results | MS | 03003, 03014 | |
| 25 Feb 2026, 18:44 | Appendix 4E and FY25 Financial Accounts | Financial Results | MS | 03003, 03011, 03012 | |
| 18 Feb 2026, 20:37 | Na Homolce to Become 3rd Site for VISABL-VT | Company Update | MS | 11001 | |
| 17 Feb 2026, 20:39 | FY25 Results Webinar | Presentations | — | 03027, 14014 |
1–50 of 82
1 / 2